Continuous Or Batch: Deciding On The Best Solution For Your Oral Solid Dose Product

By Jessica Settimi, Thermo Fisher Scientific

The transition from blockbuster drugs and large-scale production to niche drugs focused on smaller patient populations has driven a greater need for increased flexibility, faster product development, and lower costs in today’s manufacturing processes. One way to achieve these goals is by moving away from traditional batch processing and toward continuous manufacturing, which has begun to attract more interest in the industry over the last decade.